Discover
PYPD
PolyPid Ltd.
3.74
2 x 3.66
1 x 4.01
bid
ask
-
1.41
27.38%
500 @ 04:00 PM
3.69 -0.05 (1.34%)
| Ytd | -13.82% | |
| 1y | -0.27% |
3.72
day range
4.77
3.06
52 week range
5.73
| Open | 4.77 | Prev Close | 5.15 | Low | 3.72 | High | 4.77 | Mkt Cap | 38.11M |
| Vol | 2.21M | Avg Vol | 186.09K | EPS | -1.91 | P/E | -1.96 | Forward P/E | -1.36 |
| Beta | 1.40 | Short Ratio | 2.29 | Inst. Own | 36.75% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 4.83 | 200-d Avg | 4.31 | 1yr Est | 11.75 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2025-02-12 | 2024-12 | -1.05 | N/A | N/A | N/A |
| 2024-11-13 | 2024-09 | -1.07 | -1.22 | -0.15 | -14.02% |
| 2024-08-14 | 2024-06 | -1.51 | -1.25 | 0.26 | 17.22% |
| 2024-08-14 | 2024-06 | -1.51 | N/A | N/A | N/A |
| 2024-05-08 | 2024-03 | -1.96 | -1.37 | 0.59 | 30.10% |
| 2024-05-08 | 2024-03 | -1.96 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-12-16 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-11-04 | Craig-Hallum | Upgrade | Buy | |
| 2024-10-02 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-08-15 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-06-18 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-05-09 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Profile
PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | AIGH Capital Management LLC | 679.67K | 2.50M | 9.99% |
| 2024-09-29 | Rosalind Advisors, Inc. | 679.17K | 2.50M | 9.98% |
| 2024-09-29 | DAFNA Capital Management, LLC | 308.50K | 1.14M | 4.53% |
| 2024-09-29 | Stonepine Capital Management, LLC | 138.50K | 509.69K | 2.04% |
| 2024-09-29 | Adar1 Capital Management, LLC | 93.90K | 345.56K | 1.38% |
| 2024-09-29 | Yelin Lapidot Holdings Management Ltd. | 11.15K | 41.04K | 0.16% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 80.00 | 294.00 | 0.00% |
Split
| Split | Date |
|---|---|
| 1 : 30 | 2023-09-21 |